Member Info for AndyNich

Not all sells shown on LSE are real sells. This was already established and explained in this very chat.
Truspine is now number 2 share in my portfolio. It will do well.

Its good to be back

I see 7.70p on the asking now.
Ticking up nicely. There is only one way for this stock and its UP!

Gosh :) I wish I had something to do with Mr Roberts, but you guys are watching too much conspiracy themed TV shows.
I dont have a twitter account, so whoever you have followed wasn't me.
I am just a normal retail investor, which can be clearly seen by tapping on my lse profile. You will notice that I am commenting on different shares for the last year since this account was created and none of them are remotely close to TSP :)
Happy to meet for a beer and show my face :))

I can see you are very passionate about this share and I sincerely feel you want the best for it.
We just see the whole thing through a slightly different prism. It is a company that doesn't make any profit and was only IPO'd 9 months ago. At this stage, it is difficult for me to judge its performance, perhaps after 3-5 years I will have a proper clear picture, which will include revenues.
Now it is a high risk/high reward company with great potential. Nothing more, nothing less.

Are there some issues? Perhaps...
1. While Evrensel didn't pay up 250k, TSP managed to find 700k. In my eyes, that negative turned out to be a fairly positive move.
2. Companies don't have a direct impact on SP, not a single one of them.
Even great Bezos said it once: https://www.youtube.com/watch?v=msFwJ5xpg_g

I have recently come across a great article on stock manipulation:
https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated

Eventually, SP will rise. There is a reason why Oberon has bought in. I just follow the whales and make my money

3. You are correct regarding Walbrook.
PR is a bit funny one, I wouldn't want the company to spend money on PR until the product passes all its tests and gets clearances.
The recent interview with FLV was a good one. I can see folks promoting TSP on Twitter from time to time. I agree, that is a drop in the ocean, but I believe at this stage of development it doesn't need to be more than what it is.

4. Website, not sure. Never checked it for SP as I use different sources of information. It's more of a technical issue. I won't be blaming Robert if someone ****s on TSP office's doorstep. Won't argue this point though, I think it was fair for you to mention it. I am glad it's sorted now.

5.
Annabel would almost certainly sell if the investment case is no longer there. There are 3 ways, you either average down if fundamentals haven't changed, you sell if they have changed or you stay put. I don't remember any TR1s regarding her name, so option 3 is with Annabel, which again, sets the benchmark of the SP at the IPO level.

We have no evidence that Mr Patel is Mr Roberts's friend. I have lately looked at Mr Patels biography. Within 15 minutes I found all the info below. I believe he is an excellent addition, whether he is a friend of a friend or not. That guy is experienced.
He has his own website with lots of info here: http://www.nikpatel.com/
He is a very talented surgeon: https://www.bristolpost.co.uk/news/bristol-news/gran-pain-severe-considered-euthanasia-7097

https://www.nuffieldhealth.com/consultants/mr-nik-nikunj-patel

You are correct DayTrade, i know nothing about your financial situation and all other points you have made. Again, my intention is not to cause frictions here.
As a serious investor, I normally address my concerns via different channels, such as investor relations. As a shareholder, I owe a chunk of that company and the last thing on my mind would be to vent on public forum, to spread the negativity , which will potentially cause my investments going down if some twitchy soul reads that and gets to the wrong conclussion.
Now, saying that, I can see that people are very upset due to SP.
As a serious investor, you should know that entry timing is the very important part of an investment strategy. I am down as well, like everyone else

What I can see is that the progress is being made. Institutions are buying in (Oberon is now 5+ %). Annabel Schild hasn't sold and I am sure she has a bigger chunk that you and I combined.
Medical board is getting new talents in.
Another big chunk of money worth £700k is in.

Regarding your posts, I will be surprised if you can back up your claim that Mr Patel got his place on board because he plays golf with Robert.

Finally, regarding sales from USA, as per RNS on 1st of April :
https://www.investegate.co.uk/truspine-technolgs.--tsp-/rns/subscription-and-corporate-update/202104010700102174U/
"While the FDA application will be later than previously notified in the announcement of 24 December 2020, the Company is still on track for the commercial launch of the Cervi-LOK™ device during 2021."

Coins make noise, paper notes don't (c)
I have always been advocate that if your investment case changes, then you execute the sale and move on. Venting on the public forum is unprofessional at the very least, especially on the day of the good news (unless there is an agenda).

The last thing I want to do is to get to an argument,which will not do anything to the share price.
I have a substantial chunk here as well, however I am very relaxed, which probably comes with a diversified portfolio and understanding of risks when it comes to an investment.
Its irrelevant what you or I want to see when it comes to RNS. Most importantly, the progress is made and it all points towards to FDA clearance at some stage.

Lots of speculation, border line baseless accusations in your post.
Mr Patel is needed, I am suspecting that once FDA approval is done, TSP may want to pursue the CE mark and European equivalent. I zoom out and look at the bigger picture.
There are already some talents on the medical board from US side, like Dr. Mark Smith and Dr. William Lavelle.

Impatience and putting all eggs to one basket leads to these kind of conversations.

Totally disagree with you Daytrader.
Its an amazing appointment and Dr Patel is an extremely experienced surgeon based in UK, who can open the doors for us to the UK market at the very least, if not Europe.
Options at 36p sets the benchmark as to where the SP should be.
Mr Patel can certainly buy at those levels, but options are....optional to buy.
You come across as a very bitter individual, whereas I see a good progress made with 2 tests performed well, with extra 700k in the bank and all during Covid times. Company was only listed in September.
I have full confidence in Robert. I suspect that SP is being manipulated, but this has got nothing to do with the way business run in the last 6-9 months.

I dont know much about SNG and don't want to be negative towards it.
In my opinion, in general, if company has no revenue, but decent pipeline, then folks come on board on speculation that the company will do well. Its certainly higher risk, could be higher reward as well. Sounds like a lot of it is already priced in

Dvrg is simply undervalued as not much is priced in, PE ratio is low and should typically be around 10-15. I suspect this will change once we will hit guidance figures (or more)

I agree with GB too here,

If I have a problem with Sky or Vodafone, I will call their customer service or complaints department first. Perhaps if that doesn't help my next step would be to escalate this to an Ombudsman. The last thing on my mind would be to go to the shareholders forum.
Sounds like someone wants a cheaper entry point

Just get rid of the gaps

https:// t.me/ joinchat/ VJnTl44ucbL-jS5M

https://**************VJnTl44ucbL-jS5M

https://www.bbc.co.uk/news/uk-56789454

Since we have a great relationship with Liverpool, I hope we are involved.

There is also an outdoor Luna Cinema event on 23 to 25 of April in Liverpool

https://theguideliverpool.com/everything-you-need-to-know-about-liverpools-events-pilot-and-how-you-can-get-tickets/

Again, I could be barking at the wrong tree here, as I couldn't find a single hint of any breathalysers involved.
Boss tweeted a day before that deepverge is moving towards completing the trials, so I remain hopeful.

https://twitter.com/gjbrandon/status/1383078508004585483?s=19

Second day In a row when there are twice as many buys against sells.
Yesterday SP was down
Today it is held at the same level

Shocking levels of manipulation

https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated

2. Nonsense negativity on social media.

There are two different types of negative posts. The first is well thought out negative posts that show why a company isn’t doing well, or isn’t going to do well, usually backed up by data. These are fine. Usually posted by real people. Some companies are bad, and they rightfully deserve to tank.

But the second type of negative post is one like: “This stock is garbage!”

This is nonsense.

These are posted by paid manipulators or inexperienced investors frustrated by the direction of the stock price.

You can ignore these. Just mute the accounts and move on.

People are normally doing the process called Bed and ISA for a fixed fee or minimal spread via their broker. Its better that way than waiting for 2 days and buying at higher price or wider spread

Twice as many buys compared to sells
SP is down, why? Its being manipulated

https://www.griproom.com/fun/10-signs-your-stock-is-being-manipulated

One of the hardest parts of investing is when you believe in the long-term thesis, but you know the stock might go nowhere for a few quarters while the fundamentals are backfilling into an elevated stock price. Holding dead money is excruciating but necessary for big gains. (c) somewhere from Twitter

https://www.deepverge.com/investors/
Under Shareholder Information Tab. Last updated on 23rd of March this year.

Warrants
DeepVerge confirms that, as at the date of this announcement, it has 173,063,275 ordinary shares of 0.1 pence each in issue and admitted to trading on AIM under the International Securities Identification Number (“ISIN”) GB00BMGWZY29.

In addition, there are 2,123,581 unlisted warrants, with an exercise price of 20 pence per ordinary share, and an exercise period until 2 May 2021. These warrants are freely transferable and were issued on 2 May 2019.

In addition, there are 173,334 unlisted warrants, with an exercise price of 15 pence per ordinary share, and an exercise period until 5 January 2023. These warrants are freely transferable and were issued on 5 January 2018.

In addition, there are 1,890,502 unlisted warrants with an exercise price of 25.7868 pence per ordinary share and an exercise period until 15 September 2024. These warrants are freely transferable and were issued on 15 September 2020.